Rodrigo Vazquez Guillamet, MD
Associate Professor of Medicine
Education and Training
- 1999-2005 MD, Universidad Autonoma de Barcelona. Barcelona Spain
- 2006-2009 Residency, Internal Medicine, Yale School of Medicine- Bridgeport Hospital
- 2009-2012 Fellowship, Pulmonary and Critical Care- Lung Transplantation Track, Stanford University
- 2013-2019 Assistant Professor of Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico
Honors and Awards
- 2013 Travel Award, presented at the IDweek annual international meeting, by the Infectious Disease Society of America
- 2010 Travel Award, acknowledges distinguished, quality scientific research, American Thoracic Society
- 2009 Pasquale Perillie, MD Award for Outstanding Leadership and Scholarship, acknowledges Leadership and Scholarship during residency training, Department of Internal Medicine, Yale School of Medicine & Bridgeport Hospital.
- 2009 2nd position Scientific Poster Competition, acknowledges outstanding research, Connecticut Chapter, American College of Physicians
- 2009 Award to publishing residents, acknowledges peer review publication during residency training, American College of Physicians.
The focus of my clinical practice and research gravitates around chronic obstructive pulmonary disease (COPD) and lung transplantation. COPD is the leading chronic respiratory cause of death worldwide as well as the second most common indication for lung transplantation in the United States. The barriers to lung transplantation are many and include socioeconomic, medical and surgical barriers. Complementary clinical and research COPD centers can help overcome some of these barriers. During recent years I developed a multidisciplinary COPD clinic that provides detailed phenotyping of patients. As an example of complementary clinical work and research, the initial organization of the clinic benefited from the development of electronic medical record based “phenotypes” leading to personalized clinical pathways.
As transplant physicians we still can’t accurately prognosticate which COPD patients will obtain a survival benefit from lung transplantation. Understanding the natural history of the disease is essential to answering this question. My research has developed and locally validated mortality prediction rules that take into consideration competing events. This way we can help selecting the appropriate timing for transplantation.
Detecting a disease in early stages increases the chances of cure and provides more opportunities for intervention. I have experience developing a clinical severity classification for chronic bronchitis as well as new ultrasound based non-invasive diagnostic tests aiming to diagnose chronic bronchitis at its earliest stages. Both, once validated, could be used to diagnose and follow up patients with chronic bronchitis.
My goal for the near future is to help advance and meld emerging knowledge in COPD and lung transplantation.